Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...
Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of ...
Dr Michele Orini shares how machine learning can help identify critical VT ablation targets for a safer, data-driven ...
While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
2hon MSN
Beyond the brand names: Everything you need to know about Ozempic and other GPL-1 medications
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...
"I was in nappies, I was wetting myself. The fact I'm out of them is a massive achievement and something I never thought would happen." That's the relief of a 27-year-old woman who has finally been ...
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
A 33-year-old man was arrested on suspicion of possession of Class A drugs with intent to supply, with the force saying that he remains in custody for questioning. A force spokesperson said: "We've ...
Two men have been charged with class A drug offences following a raid at a property in Oldham. Police carried out a warrant at the property on Glenmore Drive in the Failsworth area on Tuesday, ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
LQT-23 is a potent, highly differentiated, first-in-class allosteric small molecule inhibitor of MSH3/MutSβ Unique mechanism of action with potential to slow or stop the progression of HD Cambridge, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results